Standards of laboratory practice: Theophylline and caffeine monitoring

Clinical Chemistry

Volumn 44, Issue 5, 1998, Pages 1124-1128

  Pesce, Amadeo J ^a   Rashkin, Mitchell ^a   Kotagal, Uma ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CIPROFLOXACIN; ENOXACIN; FLUCONAZOLE; FLUVOXAMINE; MEXILETINE; NORFLOXACIN; PIPEMIDIC ACID; PROPRANOLOL; THEOPHYLLINE; TROLEANDOMYCIN;

APNEA; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; DRUG MONITORING; GOOD LABORATORY PRACTICE; HUMAN; QUALITY CONTROL; RESPIRATORY TRACT DISEASE;

APNEA; BRONCHODILATOR AGENTS; CAFFEINE; DRUG MONITORING; HUMANS; INFANT, NEWBORN; LUNG DISEASES, OBSTRUCTIVE; QUALITY CONTROL; SPECIMEN HANDLING; THEOPHYLLINE;

EID: 0031923546     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Asthma. Lancet 1997;350(Suppl 11):1-27.
2. Sears MR. Descriptive epidemiology of asthma. Lancet 1997; 350(Suppl 11):1-4.
3. Holgate ST. The cellular and mediator basis of asthma in relation to natural history. Lancet 1997;350(Suppl 11):5-9.
4. Lipworth BJ. Treatment of acute asthma. Lancet 1997;350(Suppl 11):18-23.
5. Drugs used in the treatment of asthma: the methylxanthines, cromolyn sodium, and other agents. In: Goodman LS, Gilman AG, eds. The pharmacological basis of therapeutics, 9th ed. New York: Pergamon Press, 1996:673-82.
6. Simons FER. Asthma. In: Moyer P, Boeckx RL, eds. Applied therapeutic drug monitoring. Vol 2. Washington, DC: AACC Press, 1984:207-11.
7. Reynolds JEF, ed. Martindale. The extra pharmacopea, 29th ed. London: Pharmaceutical Press, 1993:1314-1907.
8. Pharmacy Times web site. http://www.pharmacytimes. com/top200.
9. Goodman DC, Littenberg B, O'Conner GT, Brooks JG. Theophylline in acute childhood asthma: a meta-analysis of its efficacy. Pediatr Pulmonol 1996;21:211-8.
10. Pauwells RA, Lofdahl CG, Postma DS, Tahersfield AE, O'Byrne P, Bames PJ, Ullman A. Effect of inhaled fermoterol and budesonide on exacerbations of asthma. N Engl J Med 1997;337:1405-11.
11. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Conner MB, Barnes DM. A comparison of low dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997;337:1412-8.
12. Stoloff SW. The changing role of theophylline in pediatric asthma. Am Fam Physician 1994;49:839-44.
13. Murphy DG, McDermott MF, Rydman RJ, Swan EP, Zalenski RJ. Aminophylline in the treatment of acute asthma when B-adrenergics and steroids are provided. Arch Intern Med 1993; 153:1784-8.
14. Huang D, O'Brien RG, Harman E, Aull L, Reents S, Visser J, et al. Does aminophylline benefit adults admitted to the hospital in acute exacerbation of asthma? Ann Intern Med 1993;119:1155-60.
15. DiGiulio G, Hercsmar C, Krug S, Alpert S, Marx C. Hospital treatment of asthma: lack of benefit from theophylline given in addition to nebulized albuterol and intravenously administered corticosteroid. J Pediatr 1993;122:464-9.
16. Shauss ARE, Wertheim DL, Bonagura VR, Valacer DJ. Aminophylline therapy does not improve outcome and increases adverse effects on children hospitalized with acute asthma exacerbations. Pediatrics 1994;93:205-10.
17. Edwards DJ, Zarowitz BJ, Slaughter RL. Theophylline. In: Evans WE, Schentag JJ, Jusco WJ, eds. Applied pharmacokinetics. 3rd ed. Vancouver WA: Applied Therapeutics, 1992:13.1-13.38.
18. Dasgupta A. Absorption of therapeutic drugs by barrier gels in serum separator blood collection tubes. Am J Clin Path 1994; 101:456-61.
19. Chandler MHH, Hughes JA, Clifton GD. Utility of rapid theophylline assay in clinical research. Ther Drug Monit 1989;11:365-7.
20. Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA. Goldfrank's toxicologic emergencies, 5th ed. Norwalk CT: Appleton and Lange, 1994:343.
21. Fraser CG. Standards of measurement. Desirable standards of performance for drug monitoring. Clin Chem 1987;33:387-9.
22. Warner A, Privatere A, Bates D. Antiepileptic drugs: standards of laboratory practice. Clin Chem 1998;44.
23. Piafsky KM, Oglive R. Therapeutic range - dosage of theophylline in bronchial asthma. N Engl J Med 1975;292:1218-22.
24. Mitenko PA, Ogilve RI. Rational intravenous doses of theophylline. N Engl J Med 1973;289:600-3.
25. Hansten PD, Horn JR, Koda-Kimble MA, Young LY, eds. Hansten's and Horn's drug interactions analysis and management. Vancouver, WA: Applied Therapeutics, 1997.
26. Shannon DC, Gotay F, Stein IM, Rogers MC, Todres ID, Moylan FMB. Caffeine therapy in neonates. Prevention of apnea and bradycardia in low birth weight infants. Pediatrics 1975;55:589-94.
27. Aranda JV, Grondin D, Sasyniuk BI. Pharmacologic considerations in the therapy of neonatal apnea. Pediatr Clin N Am 1981;28: 113-33.
28. Aranda JV, Turmen T, Davis J, Trippenbach T, Grinden D, Zinman R, Watters G. Effects of caffeine on control of breathing in infantile apnea. J Pediatr 1983;103:975-8.
29. Scanlon JEM, Chin KC, Mergan MEI, Durbin GM, Hale KA, Brown SS. Caffeine or theophylline for neonatal apnea? Arch of Dis Child 1992;67(Spec No 4):425-8.
30. Romagnoli C, De Carolis MP, Mujii V, Zecca E, Tortorlo G, Chiaro Hi M, et al. Effectiveness and side effects of two different doses of caffeine in preventing apnea in premature infants. Ther Drug Monit 1992;14:14-9.
31. Khanna NK, Bada HS, Somani SM. Plasma/saliva ratio caffeine concentrations. Pediatrics 1980;96:494-9.
32. Haeckel R. Relationship between intraindividual variation of the saliva/plasma and of the arteriovenous concentration ratio as demonstrated by the administration of caffeine. J Clin Chem Clin Biochem 1990;28:279-84.
33. Lee TC, Charles BG, Steer PA, Flenady VJ. Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity therapeutic drug monitoring. Ther Drug Monit 1996;18:288-93.
34. Van den Anker JN, Jengejan HTM, Sauer PJJ. Severe caffeine intoxication in a preterm neonate. Eur J Pediatr 1992;151: 466-8.
35. Kliegman RM. Chapter 87. Apnea. In: Nelson WE, Behrman RE, Kliegman RM, Arvin AM, eds. Nelson textbook of pediatrics. Philadelphia PA: WB Saunders, 1996:477-8.
36. Harrison H Jr. Apnea of prematurity: theophylline vs caffeine. Alaska Med 1992;151:466-8.
37. Gorodischer R, Karplus M. Pharmacokinetic aspects of caffeine in premature infants with apnea. Eur J Clin Pharmacol 1982;22:47-52.